Suppr超能文献

采用两日肌肉注射头孢曲松与五日阿莫西林治疗重度营养不良。

Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin.

作者信息

Dubray Christine, Ibrahim Salah A, Abdelmutalib Mohamed, Guerin Philippe J, Dantoine François, Belanger François, Legros Dominique, Pinoges Loretxu, Brown Vincent

机构信息

Epicentre, Paris, France.

出版信息

Ann Trop Paediatr. 2008 Mar;28(1):13-22. doi: 10.1179/146532808X270635.

Abstract

BACKGROUND

Systemic antibiotics are routinely prescribed for severe acute malnutrition (SAM). However, there is no consensus regarding the most suitable regimen. In a therapeutic feeding centre in Khartoum, Sudan, a randomised, unblinded, superiority-controlled trial was conducted, comparing once daily intramuscular injection with ceftriaxone for 2 days with oral amoxicillin twice daily for 5 days in children aged 6-59 months with SAM.

METHODS

Commencing with the first measured weight gain (WG) following admission, the risk difference and 95% confidence interval (95% CI) for children with a WG > or = 10 g/kg/day were calculated over a 14-day period. The recovery rate and case fatality ratio (CFR) between the two groups were also calculated.

RESULTS

In an intention-to-treat analysis of 458 children, 53.5% (123/230) in the amoxicillin group and 55.7% (127/228, difference 2.2%, 95% CI -6.9-11.3) in the ceftriaxone group had a WG > or = 10 g/kg/day during a 14-day period. Recovery rate was 70% (161/230) in the amoxicillin group and 74.6% (170/228) in the ceftriaxone group (p=0.27). CFR was 3.9% (9/230) and 3.1% (7/228), respectively (p=0.67). Most deaths occurred within the 1st 2 weeks of admission.

CONCLUSION

In the absence of severe complications, either ceftriaxone or amoxicillin is appropriate for malnourished children. However, in ambulatory programmes, especially where there are large numbers of admissions, ceftriaxone should facilitate the work of medical personnel.

摘要

背景

对于重度急性营养不良(SAM)患者,常规会开具全身性抗生素。然而,关于最合适的治疗方案尚无共识。在苏丹喀土穆的一个治疗性喂养中心,开展了一项随机、非盲、优效性对照试验,比较6至59个月患有SAM的儿童每日一次肌内注射头孢曲松2天与每日口服阿莫西林两次共5天的疗效。

方法

从入院后首次测得的体重增加(WG)开始,计算14天内体重增加≥10 g/kg/天的儿童的风险差异和95%置信区间(95%CI)。还计算了两组之间的康复率和病死率(CFR)。

结果

在对458名儿童的意向性分析中,阿莫西林组有53.5%(123/230)、头孢曲松组有55.7%(127/228,差异2.2%,95%CI -6.9 - 11.3)的儿童在14天内体重增加≥10 g/kg/天。阿莫西林组的康复率为70%(161/230),头孢曲松组为74.6%(170/228)(p = 0.27)。病死率分别为3.9%(9/230)和3.1%(7/228)(p = 0.67)。大多数死亡发生在入院后的前2周内。

结论

在没有严重并发症的情况下,头孢曲松或阿莫西林对营养不良儿童均适用。然而,在门诊项目中,尤其是入院人数众多的情况下,头孢曲松应有助于医务人员的工作。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验